Table 6.
OV-mediated gene therapy, incorporation of therapeutic genes |
Improving tumor targeting of OVs by carrier cells |
Improving T-cell costimulation by bi- or tri-specific antibodies |
Improving OV targeting of immune cells by loading the cells with tri-specific antibodies |
Combining OV therapy with checkpoint inhibitors |
Combining OV therapy with physical modalities such as mEHT |
Combining OV therapy with pharmacological modulation |